Dietas, alimentos y Enfermedad de Parkinson Idiopática

Publicado

2014-01-01

Diets, food and Idiopathic Parkinson´s disease

Palabras clave:

Parkinson Disease, Diet, Vegetarian, Diseases Prevention, Methionine (en)
Enfermedad de Parkinson, Dieta, Dieta Vegetariana, Metionina, Prevención de Enfermedades (es)

Descargas

PDF
HTML

Autores/as

José Perea-Sasiaín Facultad de Medicina. Universidad Nacional de Colombia. Bogotá, Colombia.
Roberta Hanfling Schwartz Independent scholar and lecturer, Chicago, USA

Resumen (en)
Resumen (es)

Based on two individual cases, this is a personal depict on knowledge of Idiopathic Parkinson´s Disease (IPD) etiopathogeny emphasizing diets, food and edible substances tested and reported. In the first case (adherence to an almost vegan diet, with one seventh of the protein supplied from animal origin), had an impressive beneficial effect on his fifteen years clinical course, while in the second case (continuation of a quasi ovo-lacto-vegetarian diet), did not modify substantially the clinical course. The relevance of diet on IPD focused in redistribution of protein daily intake when levodopa prescribed. Diet by itself is fundamental for the management of each individual person prone to or suffering from IPD. Vegan diets with pulses rich in protein duly balanced with cereals and supplemented with vitamin B12, reduce the intake of methionine and keep the amount of aromatic amino acids at a moderate level.

A partir de dos casos individuales, se presenta un esbozo personal sobre el conocimiento de la etiopatogenia en la Enfermedad de Parkinson Idiopática (EPI), con un énfasis en las dietas, la comida y las sustancias comestibles probadas y reportadas. En el primer caso (adherencia a una dieta prácticamente vegana, con una séptima parte de la proteína suplida de productos de origen animal), tuvo un impresionante efecto benéfico en sus quince años de desarrollo clínico, mientras que en el segundo caso (que siguió una dieta casi ovo-lacto-vegetariana) no se modificó sustancialmente el desarrollo clínico. La relevancia de la dieta en la EPI se concentra en la redistribución diaria de la ingesta de proteínas cuando se ha prescrito levodopa. La dieta por sí misma es fundamental para el manejo de cada persona predispuesta o que sufre de EPI. Las dietas veganas, ricas en proteínas debidamente balanceadas con cereales y suplementadas con vitamina B12, reducen la ingesta de metionina y mantiene la cuenta de aminoácidos aromáticos a un nivel moderado.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely, Jones; 1817. Reprinted in J Neuropsychiatry Clin Neurosci. 2002;14:223-36.

Goetz CG. Charcot on Parkinson´s disease. Mov Disord. 1986;1:27-32.

Micheli F. Enfermedad de Parkinson y trastornos relacionados. 2ª ed. Buenos Aires: Ed. Médica Panamericana; 2006.

Perea-Sasiain J. The Biosynthesis of morphine: its importance in Parkinson´s disease. rev.fac.med. 2008;56:161-89.

Perea-Sasiain J. Tiramina en la orina de los parkinsonianos idiopáticos. rev.fac.med. 2010;58:157-60.

Matsubara K, Aoyama K, Suno M, Awaya T. N-methylation underlying Parkinson's disease. Neurotoxicol Teratol. 2002;24:593-8.

Naoi M, Maruyama W, Niwa T, Nagatsu T. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin. J Neural Transm. 1994;41:197-205.

Williams AC, Hill LJ, Ramsden DB. Nicotinamide NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra. Curr Gerontol Geriatr Res. 2012;2012:302875.

Gorostidi A, Ruiz-Martínez J, Lopez de Munain A, Alzualde A, Martí Massó JF. LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity. Neurogenetics. 2009;10:157-9.

Schwartz RH. Letter to the editor on VEGAN diet. Med Hypothes. 2004;63:178.

Perea-Sasiaín J. Reflexiones sobre la biosíntesis de la morfina y el Parkinson idiopático. Revista de Salud Pública. 2007;9:308-14.

Palacios N, Gao X, McCullough ML, Jacobs EJ, Patel AV, Mayo T et al. Obesity, diabetes, and risk of Parkinson disease. Mov Disord. 2011;26:2253-9.

Mena I, Cotzias GC. Protein intake and treatment of Parkinson's disease with levodopa. N Engl J Med. 1975;292:181-4.

Cereda E, Barichella M, Pedrolli C, Pezzoli G. Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review. Mov Disord. 2010;25:2021-34.

Coimbra CG, Junqueira VB. High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients. Braz J Med Biol Res. 2003;36:1409-17.

Langan RJ, Cotzias GC. Do´s and don´ts for the patient on levodopa therapy. Am J Nurs. 1976;76:917-8.

Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord. 1999;14:21-7.

Petersen MS, Halling J, Bech S, Wermuth L, Weihe P, Nielsen F, et al. Impact of dietary exposure to food contaminants on the risk of Parkinson´s disease. Neurotoxicology. 2008;29:584-90.

Komatsu F, Kaagawa Y, Kawabata T, Kaneko Y, Chimedregzen U, Purvee B, Otgon J. A high accumulation of hair minerals in Mongolian people: 2(nd) report; influence of manganese, iron, lead, cadmium and aluminum to oxidative stress, Parkinsonism and arthritis. Curr Aging Sci. 2011;4:42-56.

Ishihara LS, Brayne C. A systematic review of nutritional risk factors of Parkinson´s disease. Nutr Res Rev. 2005;18:259-82.

Renoudet VV, Costa-Mallen P, Hopkins E. RA diet low in animal fat and rich in N-hexacosanol and fisetin is effective in reducing symptoms of Parkinson's disease. J Med Food. 2012;15:758-61.

Baroni L, Bonetto C, Tessan F, Goldin D, Cenci L, Magnanini P, et al. Pilot dietary study with normoproteic protein-redistributed plant-food diet and motor performance in patients with Parkinson's disease. Nutr Neurosci. 2011;14:1-9.

Rabey JM, Vered Y, Shabtai H, Graff E, Korczyn AD. Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption. J Neurol Neurosurg Psychiatry. 1992;55:725-7.

Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004;75:1672-7.

Tanaka K, Miyake Y, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Fukuoka Kinki Parkinson's Disease Study Group. Intake of Japanese and Chinese teas reduces risk of Parkinson's disease. Parkinsonism Relat Disord. 2011;17:446-50.

Fukushima T, Tanaka K, Ushijima K, Moriyama M. Retrospective study of preventive effect of maize on mortality from Parkinson's disease in Japan. Asia Pac J Clin Nutr. 2003;12:447-50.

Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013 May 9. doi: 10.1002/ana.23884.

Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Fukuoka Kinki Parkinson's Disease Study Group. Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson's disease: a case-control study in Japan. Parkinsonism Relat Disord. 2011;17:112-6.

Chen H, O´Reilly E, McCullough ML, Rodríguez C, Schwarzschild MA, Calle EE, et al. Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol. 2007;165:998-1006.

Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol. 2013;28:67-77.

Gillespie NG, Mena I, Cotzias GC, Bell MA. Diets affecting treatment of parkinsonism with levodopa. J Am Diet Assoc. 1973;62:525-8.

Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47:3113-20.

Cotzias GC, Papavasiliou PS, Steck A, Düby S. Parkinsonism and levodopa. Clin Pharmacol Therap. 1971;12:319-22.

Birkmayer W, Hornykiewicz O. Der L-3,4-dioxyphenylalanin (DOPA) -Effect bei der Parkinson-Akinese. Wien Klin Wochenschr. 1961;73:787-8.

Pearce LA, Waterbury LD. L-methionine: a possible levodopa antagonist. Neurology. 1974;24:840-1.

Meininger V, Flamier A, Phan T, Ferris O, Uzan A, Lefur G. Traitement de la maladie de Parkinson par la L-méthionine: résultats préliminaires. Rev Neurol (Paris). 1982;138:297-303.

Coppen A, Metcalfe M, Carroll JD, Morris JGL. Levodopa and L-tryptophan therapy in parkinsonism. Lancet. 1972;i:654-8.

Hall CD, Weiss EA, Morris CE, Prange AJ. Jr. Rapid deterioration in patients with parkinsonism following tryptophan-pyridoxine administration. Neurology. 1972;22:231-7.

Chase TN, Larry KY, Watanabe AM. Parkinson´s disease. Modification by 5-hydroxytryptophan. Neurology. 1972;22:479-84.

Beal MF. Neuroprotective effects of creatine. Amino Acids. 2011;40:1305-13.

Wassef R, Haenold R, Hansel A, Brot N, Heinemann SH, Hoshi T. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms. J Neurosci. 2007;27:12808-16.

Puca FM, Genco S, Specchio LM, Brancasi B, D'Ursi R, Prudenzano A, et al. Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease. Int J Clin Pharmacol Res. 1990;10:139-43.

Mars H. Levodopa, carbidopa and pyridoxine in Parkinson disease. Arch Neurol. 1974;30:444-7.

Murakami K, Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C et al. Parkinson's Disease Study Group, Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan. Br J Nutr. 2010;104:757-64.

McGeer PL, Zeldowicz L, McGeer EG. A clinical trial of folic acid in Parkinson's disease. Can Med Assoc J. 1972;106:145-6.

Cotzias GC, Papavasiliou PS, Ginos J, Steck A, Düby S. Metabolic modification of Parkinson's disease and of chronic manganese poisoning. Annu Rev Med. 1971;22:305-26.

Zhu BT. CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson´s disease. Int J Mol Med. 2004;13:343-53.

Singer C. Managing the patient with newly diagnosed Parkinson disease. Cleve Clin J Med. 2012;79(Suppl 2):S3-7.

Sääksjärvi K, Knekt P, Lundqvist A, Männistö S, Heliövaara M, Rissanen H, Järvinen R. A cohort study on diet and the risk of Parkinson's disease: the role of food groups and diet quality. Br J Nutr. 2013;109:329-37.

Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord. 2012;27:771-4.

Lerner E. Aaron B. Lerner, in memoriam. J Invest Dermatol. 2007;127:2077-9